Industry poised for growth, driven by advancements in precision drug discovery, rising gene therapy investments, and ...

Assay miniaturization enables high-throughput screening by reducing reaction volumes while maintaining data quality. Advances ...

To accelerate discovery, scientists from ATCC and the Broad Institute collaborated to engineer a panel of drug-resistant NSCLC models using CRISPR gene editing and gene overexpression techniques.

Men and women experience immune aging differently, affecting disease risks. New data-driven research identifies key ...

The Broad Institute’s Cancer Dependency Map Consortium (DMC) is an academic-industry collaboration that has transformed the study of cancer by developing one of the most comprehensive inventories of ...

First Ascent Biomedical's Functional Precision Oncology bridges that gap by testing living tumor cells to generate actionable data in about 10 days, helping physicians choose the right treatment ...

Researchers engineered a panel of drug-resistant NSCLC models using CRISPR gene editing and gene overexpression techniques.

Researchers say study lays groundwork for tailored sex-specific strategies to monitor and improve immune health across lifespan.

At its core, GPT-Rosalind is the first in a new series of models optimized for scientific workflows. While previous ...

Researchers at Karolinska Institutet have developed CDKPredX, a gene expression-based model that identifies breast cancer tumors unlikely to respond to pre-surgery chemotherapy but more responsive to ...

Benjamin Karikari, a crop genetics researcher at Nebraska, focuses on farmer-driven soybean and crop systems research, ...